Neurocrine Biosciences | Aset Lancar





Aset Lancar Perubahan Tanggal
AbbVie USD 29.06B 523M 2025-12
Acadia Pharmaceuticals USD 1.08B 115.87M 2025-09
Agios Pharmaceuticals USD 942.05M 91.06M 2025-12
ALKERMES USD 1.74B 106.38M 2025-09
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
Amgen USD 29.06B 1.17B 2025-12
Biogen USD 8.97B 37.5M 2025-12
BioMarin Pharmaceutical USD 3.85B 49.21M 2025-09
Cytokinetics USD 977.35M 90.81M 2025-09
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Exelixis USD 1.44B 41.03M 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
Halozyme Therapeutics USD 825.21M 503.54M 2025-12
Incyte USD 5.02B 746.01M 2025-12
Ionis Pharmaceuticals USD 2.52B 58.16M 2025-09
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Prothena USD 339.97M 45.51M 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Repligen USD 1.1B 39.62M 2025-09
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Sarepta Therapeutics USD 2.72B 65.32M 2025-09
Teva Pharmaceutical Industries USD 13.95B 1.21B 2025-12
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12
Xoma USD 110.71M 5.78M 2025-09


Neurocrine Biosciences Aset Lancar - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Feb 2026.